India Glycols Shines in Q3 & 9M FY26 with Record Performance and Strategic Restructuring

India Glycols Limited (IGL), a prominent player in the bio-based chemicals and spirits sector, has reported an exceptional financial performance for the third quarter and nine months ended FY26. The company achieved its highest-ever net turnover and EBITDA, underscoring its robust operational capabilities and strategic initiatives. For the nine-month period (9MFY26), IGL's net revenue surged by 11.4% to ₹3,235 Crore, while EBITDA witnessed an impressive 28.9% growth, reaching ₹487 Crore. This strong performance translated into a healthy EBITDA margin of 15.0%, a significant expansion from the previous year. The Profit After Tax (PAT) also grew by 23.4% to ₹206 Crore, reflecting enhanced profitability and efficient management.

The company's diversified portfolio, spanning Bio-based Specialties and Performance Chemicals (BSPC), Potable Spirits (PS), Bio-Fuel (BF), and Ennature Biopharma (EB), contributed to this growth. The Potable Spirits segment delivered a strong performance, with net revenue growing by 17% year-on-year in 9MFY26 to ₹1,025 Crore, driven by a 5% increase in cases sold. This growth was supported by a dual strategy focusing on product innovation, premiumisation, and regional expansion, including strategic partnerships like the one with Amrut and the launch of new brands in high-potential markets such as Kerala and the CSD (Canteen Stores Department) channel. The Bio-Fuel segment also registered substantial growth, with revenue increasing by 51.2% in 9MFY26 to ₹1,165 Crore, benefiting from India's ethanol blending program and the company's integrated ethanol manufacturing capabilities. The BSPC segment showcased an outstanding EBITDA performance, up 68% in Q3 and 26% for 9M, attributed to a focus on high-margin products and operational cost reductions. While the Ennature Biopharma segment faced a challenging operating environment, leading to a decline in EBIT, the company is actively pursuing new customer additions and branded launches to stabilize performance.

Strategic Initiatives and Future Outlook

IGL's management has been proactive in implementing strategic initiatives to sustain its growth trajectory. A significant highlight is the substantial debt reduction of ₹582 Crore, achieved through a preferential allotment of ₹467 Crore and internal accruals. The company is also actively swapping high-cost debt for lower-cost alternatives, which is expected to yield considerable interest savings from Q4 FY26 onwards. This disciplined approach to capital allocation strengthens the company's balance sheet and improves its financial flexibility.

Looking ahead, IGL is undertaking a major corporate restructuring through a demerger scheme. The Bio Pharma undertaking will be separated into Ennature Bio Pharma Limited, and the Spirits & Biofuel Undertaking will form IGL Spirits Limited. The National Company Law Tribunal (NCLT) approved this scheme on January 15, 2026, with an appointed date of April 1, 2026. This demerger is designed to unlock shareholder value, provide each business with a clear strategic focus, and enable independent growth pathways. The management believes this will attract focused investors and optimize resource allocation for each distinct entity.

Innovation and Market Positioning

IGL's commitment to innovation, particularly in green chemistry, remains a core pillar of its strategy. The company is a pioneer in producing bio-ethylene glycols from renewable agro-resources and is India's leading green chemical company. Its state-of-the-art R&D center, approved by the Department of Scientific & Industrial Research (DSIR), continuously works on next-generation products and sustainable solutions. The pipeline for new Performance Chemicals is strong, with products derived from C-smart or purple alcohol, bio-based specialties, iGreen solvents, and APIs/Nutraceuticals. These innovations are geared towards high-growth sectors like automotive, packaging, pharma, and personal care.

Management's commentary highlighted a balanced perspective, acknowledging global volatility and pricing pressures while emphasizing the company's strong positioning and strategic advantages. The ability to leverage in-house ethanol production provides a significant competitive edge across its Bio-Fuel and Potable Spirits segments. The company's proactive debt management and strategic restructuring demonstrate a clear vision for long-term value creation and sustainable growth. India Glycols Limited is well-positioned to capitalize on the increasing demand for sustainable products and expand its market presence through a focused and innovative approach.